Gillheeney Gary S.'s Form 4 filing
Organogenesis Holdings Inc. (ORGO) · filed Dec 12, 2024
- Accession no.
- 0001062993-24-020566
- Filed
- Dec 12, 2024
- Trade date
- Dec 10-12, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market sales total $940.1K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Gillheeney Gary S.CIK 0001757373 | Director, Officer (President and CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 10, 2024 | Class A Common Stock | SSaleDisposed | −58,525 | $3.64 | −$213,031 | 3,301,201 | Direct | |
| Dec 11, 2024 | Class A Common Stock | SSaleDisposed | −157,448 | $3.64 | −$573,110.72 | 3,143,753 | Direct | |
| Dec 12, 2024 | Class A Common Stock | SSaleDisposed | −43,359 | $3.55 | −$153,924.45 | 3,100,394 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.